Norbrook Laboratories is an API and finished-dose manufacturer based in United Kingdom. It holds 4 valid CEPs across a filed portfolio of 3 molecules. Its filings concentrate with MPA (SE), Health Canada and URPL (PL). Its GMP standing is certified by MHRA (UK).
| Site | FDA FEI |
|---|---|
| NEWRY, United Kingdom | Not on file |
| United Kingdom, United Kingdom | 3005587188 |
| Newry, Ireland | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Oxytetracycline | EDQM | 2 |
| Flunixin Meglumine For Veterinary Use | EDQM | 1 |
| Meloxicam | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MPA (SE) | 89 | None |
| Health Canada | 70 | None |
| URPL (PL) | 31 | None |
| NPRA (MY) | 5 | None |
| EMA | 2 | None |
| DKMA (DK) | 1 | None |
| MHRA (UK) | None | 2 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Norbrook Laboratories comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.